Publication:
The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study

dc.contributor.authorUrquidi, Cinthya
dc.contributor.authorSantelices, Emilio
dc.contributor.authorLagomarcino. Anne
dc.contributor.authorValenzuela, María
dc.contributor.authorLarrañaga, Nicolás
dc.contributor.authorGonzález, Emilio
dc.contributor.authorPavez, Axel
dc.contributor.authorWosiack, Amanda
dc.contributor.authorMaturana, Marcela
dc.contributor.authorMoller, Paulina
dc.contributor.authorTorres, Juan
dc.contributor.authorMuñoz, Sergio
dc.contributor.authorO’Ryan, Miguel
dc.date.accessioned2023-05-03T16:37:50Z
dc.date.available2023-05-03T16:37:50Z
dc.date.issued2023
dc.description.abstractBackground: World Health Organization approved vaccines have demonstrated relatively high protection against moderate to severe COVID-19. Prospective vaccine effectiveness (VE) designs with first-hand data and population-based controls are nevertheless rare. Neighborhood compared to hospitalized controls, may differ in compliance to non-pharmacuetical interventions (NPI) compliance, which may influence VE results in real-world settings. We aimed to determine VE against COVID-19 intensive-care-unit (ICU) admission using hospital and community-matched controls in a prospective design. Methods: We conducted a multicenter, observational study of matched cases and controls (1:3) in adults ≧18 years of age from May to July 2021. For each case, a hospital control and two community controls were matched by age, gender, and hospital admission date or neighborhood of residence. Conditional logistic regression models were built, including interaction terms between NPIs, lifestyle behaviors, and vaccination status; the model's β coefficients represent the added effect these terms had on COVID-19 VE. Results: Cases and controls differed in several factors including education level, obesity prevalence, and behaviors such as compliance with routine vaccinations, use of facemasks, and routine handwashing. VE was 98·2% for full primary vaccination and 85·6% for partial vaccination when compared to community controls, and somewhat lower, albeit not significantly, compared to hospital controls. A significant added effect to vaccination in reducing COVID-19 ICU admission was regular facemask use and VE was higher among individuals non-compliant with the national vaccine program, and/or tonroutine medical visits during the prior year. Conclusion: VE against COVID-19 ICU admission in this stringent prospective case-double control study reached 98% two weeks after full primary vaccination, confirming the high effectiveness provided by earlier studies. Face mask use and hand washing were independent protective factors, the former adding additional benefit to VE. VE was significantly higher in subjects with increased risk behaviors.
dc.identifier.citationUrquidi C, Santelices E, Lagomarcino AJ, Teresa Valenzuela M, Larrañaga N, Gonzalez E, Pavez A, Wosiack A, Maturana M, Moller P, Pablo Torres J, Muñoz S, O'Ryan G M. The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study. Vaccine. 2023 Apr 3:S0264-410X(23)00354-7. doi: 10.1016/j.vaccine.2023.03.060.
dc.identifier.doihttps://doi.org/10.1016/j.vaccine.2023.03.060
dc.identifier.urihttps://repositorio.udd.cl/handle/11447/7437
dc.language.isoen
dc.subjectCOVID-19
dc.subjectVaccine effectiveness
dc.subjectNon-pharmacological intervention
dc.subjectSARS-Cov-2
dc.subjectRisk factors
dc.titleThe added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceVaccine
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
4.The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile.pdf
Size:
1.04 MB
Format:
Adobe Portable Document Format
Description:
Texto completo
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.63 KB
Format:
Item-specific license agreed upon to submission
Description: